tinea%20unguium
TINEA UNGUIUM
Onychomycosis is a fungal infection of the nail bed, nail plate or both. It is caused by dermatophytes, non-dermatophyte molds and yeast.
Tinea unguium or dermatophytic onychomycosis is a dermatophyte infection of the nail more commonly affecting the toenails than the fingernails.
It is usually asymptomatic and patients first consult for cosmetic reasons.
It is suspected if there are changes in the 3rd or 5th toenail, involvement of the 1st and 5th toenails on the same foot and unilateral nail changes.

Patient Education

  • Educate patient about proper foot hygiene
    • Patients should wear breathable footwear & 100% cotton socks
    • Change socks often, if possible
    • Keep feet dry throughout the day, may use antifungal foot powder
    • Recognize & treat Tinea pedis to prevent spread to toenails
  • Patient should be encouraged to maintain & improve health conditions
    • Eg regularly trim nails short, control diabetes mellitus (DM), quit smoking, exercise, etc
  • Assure patient that improvement continues even after cessation of oral treatment since the fungus is continually exposed to the medication secondary to the drug’s binding to keratin in the nail, though recurrence is common
    • May take 9-12 months to assess cure
Editor's Recommendations
Most Read Articles
28 May 2019
Trifarotene is safe, well-tolerated and effective in treating both facial and truncal acne, according to two phase III trials.
08 May 2019
Antinuclear antibody (ANA) negativity appears to increase the likelihood of developing malignancy in patients with adult-onset dermatomyositis (DM) within 3 years of diagnosis of their DM, according to a recent study.
20 May 2019
Three treatments of ablative fractional CO2 laser (AFCO2L) yield improvements in burn scar pain, itch and dermal architecture 6 weeks after treatment, a recent study has found.
11 Apr 2019
Immune checkpoint inhibitor therapy may lead to various inflammatory reactions with differing degrees of severity, suggests a recent study. Most rashes respond to topical treatment, but immunotherapy is often interrupted by immunobullous and exfoliative presentations.